References
- Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012;55:2005-23
- Watanabe S, Hashimoto E, Ikejima K, et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Hepatol Res 2015;45:363-77
- National Institute for Health and Care Excellence (NICE) guideline. Cirrhosis in over 16s: assessment and management. Methods, evidence and recommendations. July 2016. Available at: https://www.nice.org.uk/guidance/ng50
- Bril F, Kalavalapalli S, Clark VC, et al. Response to pioglitazone in patients with nonalcoholic steatohepatitis with vs without type 2 diabetes. Clin Gastroenterol Hepatol 2018;16:558-66.e2
- Argo CK, Patrie JT, Lackner C, et al. Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trial. J Hepatol 2015;62:190-7
- Yki-Järvinen H. Nutritional modulation of non-alcoholic fatty liver disease and insulin resistance. Nutrients 2015;7:9127-38
- De Sousa SM, Norman RJ. Metabolic syndrome, diet and exercise. Best Pract Res Clin Obstet Gynaecol 2016;37:140-51
- Harvie M, Howell A. Potential benefits and harms of intermittent energy restriction and intermittent fasting amongst obese, overweight and normal weight subjects – a narrative review of human and animal evidence. Behav Sci (Basel) 2017;7:E4
- Kleiner DE, Brunt EM, Van Natta M, et al. Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-21
- Alberti KG, Eckel RH, Grundy SM, et al. International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5
- Hamaguchi M, Kojima T, Itoh Y, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007;102:2708-15
- Oshakbayev KP. Clinical Management of Metabolic Syndrome. Practice Guidance Ed. by Prof. Abylaiuly Zh. Almaty: Ziat Press, 2007
- Oshakbayev K, Dukenbayeva B, Togizbayeva G, et al. Weight loss technology for people with treated type 2 diabetes: a randomized controlled trial. Nutr Metabol 2017;14:11
- Petersen KF, Dufour S, Befroy D, et al. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 2005;54:603-8
- Lemke H, Carver T, Court O, Andersen R. The impact of excess weight loss on bone mineral density ten years following bariatric surgery. Can J Diabetes 2013;37:S257
- Tilg H, Moschen A. Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease. Minerva Gastroenterol Dietol 2010;56:159-68
- Musso G, Gambino R, Cassader M, Pagano G. A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease. Hepatology 2011;52:79-104
- Koster-Rasmussen R, Simonsen MK, Siersma V, et al. Intentional weight loss and longevity in overweight patients with type 2 diabetes: a population-based cohort study. PLoS One 2016;11:e0146889
- Vilar-Gomez E, Yasells-Garcia A, Martinez-Perez Y, et al. Development and validation of a noninvasive prediction model for nonalcoholic steatohepatitis resolution after lifestyle intervention. Hepatology 2016;63:1875-87
- O’Donnell M, Mente A, Yusuf S. Low sodium intake and cardiovascular health: an unanswered question. Response to: Letter from Dr N. Campbell, “Dissidents and dietary sodium. Concerns about the commentary by O’Donnell et al.” Int J Epidemiol 2017;46:367-9
- Bruder-Nascimento T, Silva ST, Boer PA, Cordellini S. Effects of exercise training on stress-induced vascular reactivity alterations: role of nitric oxide and prostanoids. Braz J Phys Ther 2015;19:177-85
- Gomes JM, Costa JA, Alfenas RC. Metabolic endotoxemia and diabetes mellitus: a systematic review. Metabolism 2017;68:133-44
- Pestana D, Faria G, Sa C, et al. Persistent organic pollutant levels in human visceral and subcutaneous adipose tissue in obese individuals – depot differences and dysmetabolism implications. Environ Res 2014;133:170-7
- Artacho-Cordon F, Leon J, Saenz JM, et al. Contribution of persistent organic pollutant exposure to the adipose tissue oxidative microenvironment in an adult cohort: a multipollutant approach. Environ Sci Technol 2016;50:13529-38
- Crisafulli A, Marongiu E, Ogoh S. Cardiovascular reflexes activity and their interaction during exercise. Biomed Res Int 2015; 394183
- Jiang M, Xin J, Zou Q, Shen JW. A research on the relationship between ejaculation and serum testosterone level in men. J Zhejiang Univ Sci 2003;4:236-40
- Hamilton LD, Meston CM. The effects of partner togetherness on salivary testosterone in women in long distance relationships. Horm Behav 2010;57:198-202
- Boren J, Taskinen MR, Olofsson SO, Levin M. Ectopic lipid storage and insulin resistance: a harmful relationship. J Intern Med 2013;274:25-40
- Saltiel AR. Insulin resistance in the defense against obesity. Cell Metab 2012;15:798-804
- Luo L, Liu M. Adipose tissue in control of metabolism. J Endocrinol 2016;231:R77-99